SMS-oncology Revenue and Competitors
Estimated Revenue & Valuation
- SMS-oncology's estimated annual revenue is currently $23.3M per year.
- SMS-oncology's estimated revenue per employee is $155,000
Employee Data
- SMS-oncology has 150 Employees.
- SMS-oncology grew their employee count by -18% last year.
SMS-oncology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10.5M | 68 | -36% | N/A | N/A |
#2 | $10.4M | 67 | -7% | N/A | N/A |
#3 | $9.6M | 62 | 11% | N/A | N/A |
#4 | $6.8M | 44 | 2% | N/A | N/A |
#5 | $23.3M | 150 | -18% | N/A | N/A |
#6 | $35.8M | 231 | 9% | N/A | N/A |
#7 | $13.6M | 88 | 9% | N/A | N/A |
#8 | $14.7M | 95 | 14% | N/A | N/A |
#9 | $3.6M | 23 | -70% | N/A | N/A |
#10 | $8.8M | 57 | 19% | N/A | N/A |
What Is SMS-oncology?
SMS-oncology is a full-service oncology CRO that in addition to clinical operations provides expert advice on oncology drug development. We are specialized in the execution of early phase oncology and immuno-oncology trials throughout Europe. Our unique competence and value proposition is providing Direction to our sponsors along the Drug-Data-Dossier path (our 4D service).
keywords:N/AN/A
Total Funding
150
Number of Employees
$23.3M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SMS-oncology News
... announcement urges everyone to stay vigilant against emails, SMS, ... on the operation of radiotherapy in the hospital's oncology unit.
Cytovation – Norway-based Cytovation AS announced that SMS-Oncology has been selected as the contract research organization that will ...
SMS-oncology is developing the protocol and giving guidance regarding patient inclusion criteria and investigational sites for a best-fit and ...
SMS oncology are one of the few full-service contract research organisation that exclusively researches oncology. SMS oncology specialises in ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $26.3M | 165 | 4% | N/A |
#2 | $58.2M | 215 | 21% | N/A |
#3 | $62.9M | 252 | 8% | N/A |
#4 | $101.8M | 331 | N/A | N/A |
#5 | $2659.4M | 8368 | 4% | N/A |